Skip to main content
. 2018 Dec 5;8(1):289–304. doi: 10.1002/cam4.1905

Figure 8.

Figure 8

Significant mutation genes with prognostic value in KIRC in 281 TCGA patients with mutation information (137 high‐risk patients and 138 low‐risk patients and six patients without expression data). A and B, The mutant status of PBRM1 and SETD2 was closely related with patients' prognosis. C, The mutation profiles of PBRM1 and SETD2 between high‐ and low‐risk groups. High‐risk group achieved higher mutation frequency than low‐risk group (SETD2: high risk 4.27% vs low risk 1.78%; PBRM1: high risk 2.49% vs low risk 1.78%)